The efficacy of DAAs against the patients with chronic hepatitis and cirrhosis due to HCV

The efficacy of DAAs against the patients with chronic hepatitis and cirrhosis due to HCV - The efficacy of DAAs

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018098

Enrollment

300

Registered

2015-06-26

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the patients with chronic hepatitis and cirrhosis due to HCV

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients with chronic hepatitis and cirrhosis due to HCV

Exclusion criteria

Exclusion criteria: inadequate patients

Design outcomes

Primary

Measure	Time frame
SVR rate	—

Secondary

Measure	Time frame
adverse event	—

Countries

Japan

Contacts

Public ContactHirotoshi Ebinuma

School of Medicine, Keio University Division of Gastrenterology & Hepatology

h-ebi@xj8.so-net.ne.jp03-3353-1211-62384

Outcome results